Review




Structured Review

Pfizer Inc clindamycin pfizer injectables
Summary of effects of hepatic impairment on PK parameters and dosing recommendations, as described in package insert, unless otherwise noted.
Clindamycin Pfizer Injectables, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/clindamycin pfizer injectables/product/Pfizer Inc
Average 90 stars, based on 1 article reviews
clindamycin pfizer injectables - by Bioz Stars, 2026-06
90/100 stars

Images

1) Product Images from "Relevance of liver failure for anti-infective agents: from pharmacokinetic alterations to dosage adjustments"

Article Title: Relevance of liver failure for anti-infective agents: from pharmacokinetic alterations to dosage adjustments

Journal: Therapeutic Advances in Infectious Disease

doi: 10.1177/2049936113519089

Summary of effects of hepatic impairment on PK parameters and dosing recommendations, as described in package insert, unless otherwise noted.
Figure Legend Snippet: Summary of effects of hepatic impairment on PK parameters and dosing recommendations, as described in package insert, unless otherwise noted.

Techniques Used: Clinical Proteomics, Protease Inhibitor, Infection, Formulation



Similar Products

90
Pfizer Inc clindamycin pfizer injectables
Summary of effects of hepatic impairment on PK parameters and dosing recommendations, as described in package insert, unless otherwise noted.
Clindamycin Pfizer Injectables, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/clindamycin pfizer injectables/product/Pfizer Inc
Average 90 stars, based on 1 article reviews
clindamycin pfizer injectables - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

Image Search Results


Summary of effects of hepatic impairment on PK parameters and dosing recommendations, as described in package insert, unless otherwise noted.

Journal: Therapeutic Advances in Infectious Disease

Article Title: Relevance of liver failure for anti-infective agents: from pharmacokinetic alterations to dosage adjustments

doi: 10.1177/2049936113519089

Figure Lengend Snippet: Summary of effects of hepatic impairment on PK parameters and dosing recommendations, as described in package insert, unless otherwise noted.

Article Snippet: Clindamycin (Pfizer Injectables) , • Increased t 1/2 in moderate and severe impairment , No adjustment , , Monitor hepatic function.

Techniques: Clinical Proteomics, Protease Inhibitor, Infection, Formulation